ATE463528T1 - Vernetzte aminpolymere - Google Patents

Vernetzte aminpolymere

Info

Publication number
ATE463528T1
ATE463528T1 AT05747577T AT05747577T ATE463528T1 AT E463528 T1 ATE463528 T1 AT E463528T1 AT 05747577 T AT05747577 T AT 05747577T AT 05747577 T AT05747577 T AT 05747577T AT E463528 T1 ATE463528 T1 AT E463528T1
Authority
AT
Austria
Prior art keywords
amine polymers
cross
linked amine
methods
treatment
Prior art date
Application number
AT05747577T
Other languages
English (en)
Inventor
Han Chang
Dominique Charmot
Eric Connor
Florence Roger
Original Assignee
Ilypsa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/965,044 external-priority patent/US7459502B2/en
Priority claimed from US10/980,991 external-priority patent/US7608674B2/en
Application filed by Ilypsa Inc filed Critical Ilypsa Inc
Application granted granted Critical
Publication of ATE463528T1 publication Critical patent/ATE463528T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/01—Use of inorganic substances as compounding ingredients characterized by their specific function
    • C08K3/011—Crosslinking or vulcanising agents, e.g. accelerators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Peptides Or Proteins (AREA)
  • Optical Modulation, Optical Deflection, Nonlinear Optics, Optical Demodulation, Optical Logic Elements (AREA)
AT05747577T 2004-10-13 2005-05-11 Vernetzte aminpolymere ATE463528T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/965,044 US7459502B2 (en) 2003-11-03 2004-10-13 Pharmaceutical compositions comprising crosslinked polyamine polymers
US10/980,991 US7608674B2 (en) 2003-11-03 2004-11-03 Pharmaceutical compositions comprising cross-linked small molecule amine polymers
PCT/US2004/036745 WO2005041902A2 (en) 2003-11-03 2004-11-03 Anion-binding polymers and uses thereof
PCT/US2005/009394 WO2005092039A2 (en) 2004-03-22 2005-03-22 Crosslinked amine polymers
PCT/US2005/016437 WO2006043984A2 (en) 2004-10-13 2005-05-11 Crosslinked amine polymers

Publications (1)

Publication Number Publication Date
ATE463528T1 true ATE463528T1 (de) 2010-04-15

Family

ID=36203360

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05747577T ATE463528T1 (de) 2004-10-13 2005-05-11 Vernetzte aminpolymere

Country Status (10)

Country Link
EP (1) EP1831266B1 (de)
JP (1) JP2008531751A (de)
CN (1) CN101065409A (de)
AT (1) ATE463528T1 (de)
AU (1) AU2005296290A1 (de)
CA (1) CA2583634C (de)
DE (1) DE602005020501D1 (de)
ES (1) ES2342947T3 (de)
MX (1) MX2007004407A (de)
WO (1) WO2006043984A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
JP2009507019A (ja) 2005-09-02 2009-02-19 ジェンザイム・コーポレーション リン酸塩を除去する方法およびそれに使用される重合体
WO2008042222A2 (en) 2006-09-29 2008-04-10 Genzyme Corporation Amide dendrimer compositions
WO2008076242A1 (en) 2006-12-14 2008-06-26 Genzyme Corporation Amido-amine polymer compositions
WO2009023544A2 (en) * 2007-08-10 2009-02-19 Ilypsa, Inc. Dosage unit anion-exchange polymer pharmaceutical compositions
JP5332520B2 (ja) * 2007-11-07 2013-11-06 アステラス製薬株式会社 医薬用錠剤
CA2790901C (en) * 2010-02-24 2018-05-01 Relypsa, Inc. Amine polymers for use as bile acid sequestrants
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
CN102342955A (zh) * 2011-08-04 2012-02-08 昆明邦宇制药有限公司 一种治疗高磷血症的药物组合物及其制剂
CN102675510B (zh) * 2012-05-28 2014-04-02 诚达药业股份有限公司 司维拉姆的合成工艺
ES2733493T3 (es) * 2013-06-05 2019-11-29 Tricida Inc Polímeros de unión a protones para la administración oral
JP6992084B2 (ja) * 2017-10-16 2022-01-13 富士フイルム株式会社 高リン血症治療剤
CA3079171C (en) * 2017-10-16 2023-09-12 Fujifilm Corporation Therapeutic agent for hyperphosphatemia and particles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5879022A (ja) * 1981-11-04 1983-05-12 Bitamin Kenkyusho:Kk 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤
FR2680791B1 (fr) * 1991-08-30 1994-09-09 Bp Chemicals Snc Procede de fabrication d'un polymere reticule et utilisation du polymere.
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
MY133977A (en) * 2000-06-16 2007-11-30 Nippon Catalytic Chem Ind Crosslinked polymers containing tertiary amine and/or quaternary ammonium salt structures, processes for making and uses thereof
JP3931639B2 (ja) * 2001-11-19 2007-06-20 セイコーエプソン株式会社 インクジェットプリンタに使用するための水性インク組成物
CA2412691C (en) * 2002-11-25 2008-02-26 Mac & Mac Hydrodemolition Inc. Scarifying apparatus for interior surface of pipeline

Also Published As

Publication number Publication date
EP1831266B1 (de) 2010-04-07
WO2006043984A2 (en) 2006-04-27
ES2342947T3 (es) 2010-07-19
JP2008531751A (ja) 2008-08-14
EP1831266A4 (de) 2007-12-05
CA2583634A1 (en) 2006-04-27
MX2007004407A (es) 2007-07-17
WO2006043984A3 (en) 2006-08-24
EP1831266A2 (de) 2007-09-12
DE602005020501D1 (de) 2010-05-20
CN101065409A (zh) 2007-10-31
CA2583634C (en) 2013-03-19
AU2005296290A1 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
WO2005092039A3 (en) Crosslinked amine polymers
GB2430624B (en) Ion binding compositions
ATE463528T1 (de) Vernetzte aminpolymere
GB2446076A (en) Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
EP2166991A4 (de) Pva-paa-hydrogele
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
EA200600078A1 (ru) Способы и композиции для лечения амилоидных заболеваний
WO2005041900A3 (en) Polyamine polymers
EP1844077A4 (de) Dr5-antikörper und deren verwendung
WO2006125082A3 (en) Hydrogels and hydrogel particles
WO2006058868A3 (de) Substituierte pteridine zur behandlung von entzündlichen erkrankungen
WO2005000208A3 (en) Combination therapy for the treatment of neoplasms
WO2006093813A3 (en) Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
WO2008008491A3 (en) Implantable medical devices and coatings therefor comprising physically crosslinked block copolymers
EA200501528A1 (ru) Применение кластерина для лечения и/или профилактики периферических неврологических заболеваний
TW200716088A (en) Formulations and methods for treating amyloidosis
EA200901062A1 (ru) Использование ингибиторов растворимой эпоксидгидролазы для предотвращения и лечения метаболического синдрома и соответствующих расстройств
WO2007038801A3 (en) Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof
ATE453383T1 (de) Ionenbindende zusammensetzungen
WO2004105696A3 (en) Combination therapy for the treatment of neoplasms
WO2009018429A3 (en) TREATMENT OF CANCER VIA TARGETING OF IL-13 RECEPTOR-α2
WO2004073631A3 (en) Combination therapy for the treatment of neoplasms
WO2006116583A3 (en) Compositions comprising a polymerized benzimidazole and a buffering agent and methods of using same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties